Cargando…
Successful adalimumab graded challenge after allergic delayed reaction to golimumab in a woman with rheumatoid arthritis
A graded challenge with adalimumab could be safe in case of a delayed allergic reaction to golimumab, after a detailed allergological evaluation and the exclusion of allergic sensitization using skin tests.
Autores principales: | Rivolta, Federica, Sangalli, Andrea, Cappelletti, Camilla, Chiei Gallo, Alessandra, Dubini, Marco, Pravettoni, Valerio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037302/ https://www.ncbi.nlm.nih.gov/pubmed/36968346 http://dx.doi.org/10.1002/ccr3.7067 |
Ejemplares similares
-
Successful fractionated undiluted doses of COVID‐19 vaccine in five cases of suspected allergic reactions to the first dose
por: Rivolta, Federica, et al.
Publicado: (2022) -
Venom immunotherapy: safety and tolerability of the build‐up phase with depot versus aqueous preparations
por: Pravettoni, Valerio, et al.
Publicado: (2022) -
Golimumab for Rheumatoid Arthritis
por: Pelechas, Eleftherios, et al.
Publicado: (2019) -
Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
por: Dubini, Marco, et al.
Publicado: (2023) -
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
por: Lanz, Sofia, et al.
Publicado: (2021)